Crew Capital Management’s Gilead Sciences GILD Stock Holding History

Crew Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$263K	Sell	2,084 -15	-0.7%	-$1.98K	0.14%	98
2026 Q1	$293K	Sell	2,099 -473	-18%	-$66.2K	0.19%	91
2025 Q4	$316K	Hold	2,572	–	–	0.2%	87
2025 Q3	$285K	Hold	2,572	–	–	0.19%	92
2025 Q2	$285K	Sell	2,572 -4,509	-64%	-$480K	0.2%	96
2025 Q1	$793K	Sell	7,081 -259	-4%	-$26.7K	0.65%	60
2024 Q4	$678K	Sell	7,340 -6,479	-47%	-$583K	0.56%	65
2024 Q3	$1.16M	Buy	+13,819	New	+$1.05M	0.93%	23
2024 Q1	–	Sell	-4,913	Closed	-$398K	–	123
2023 Q4	$398K	Buy	4,913 +954	+24%	+$74.2K	0.41%	50
2023 Q3	$297K	Buy	3,959 +11	+0.3%	+$846	0.32%	58
2023 Q2	$304K	Hold	3,948	–	–	0.35%	63
2023 Q1	$328K	Hold	3,948	–	–	0.47%	55
2022 Q4	$339K	Hold	3,948	–	–	0.49%	53
2022 Q3	$244K	Hold	3,948	–	–	0.33%	78
2022 Q2	$244K	Hold	3,948	–	–	0.31%	81
2022 Q1	$235K	Hold	3,948	–	–	0.23%	93
2021 Q4	$287K	Hold	3,948	–	–	0.24%	87
2021 Q3	$276K	Hold	3,948	–	–	0.26%	83
2021 Q2	$272K	Hold	3,948	–	–	0.25%	84
2021 Q1	$255K	Buy	+3,948	New	+$255K	0.25%	88

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Crew Capital Management's GILD Position: Q2 2026 in Review

Crew Capital Management reduced its Gilead Sciences (GILD) stake by 0.71% in Q2 2026, selling an estimated $1.98K and leaving 2,084 shares worth $263K. The position accounts for 0.14% of the portfolio, ranked #98.

Crew Capital Management first reported a position in GILD in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.16M in Q3 2024. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Crew Capital Management held 2,084 shares of Gilead Sciences worth $263K as of Q2 2026.
Crew Capital Management sold 15 Gilead Sciences shares in Q2 2026, an estimated $1.98K.
Gilead Sciences made up 0.14% of Crew Capital Management's portfolio in Q2 2026, its #98 holding.
Crew Capital Management first reported a position in Gilead Sciences in Q1 2021 and has held it in 20 quarters since.
Crew Capital Management's Gilead Sciences position peaked at $1.16M in Q3 2024.
2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Crew Capital Management's 13F filing for Q2 2026, filed 3 Aug 2026.